Harvard Bioscience (FRA:HBI) Long-Term Debt : €29.34 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Harvard Bioscience Long-Term Debt?

Harvard Bioscience's Long-Term Debt for the quarter that ended in Mar. 2024 was €29.34 Mil.

Harvard Bioscience's quarterly Long-Term Debt declined from Sep. 2023 (€33.05 Mil) to Dec. 2023 (€28.16 Mil) but then increased from Dec. 2023 (€28.16 Mil) to Mar. 2024 (€29.34 Mil).

Harvard Bioscience's annual Long-Term Debt increased from Dec. 2021 (€39.91 Mil) to Dec. 2022 (€40.60 Mil) but then declined from Dec. 2022 (€40.60 Mil) to Dec. 2023 (€28.16 Mil).

Harvard Bioscience Long-Term Debt Historical Data

The historical data trend for Harvard Bioscience's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Long-Term Debt Chart

Harvard Bioscience Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

42.23

38.05

39.91

40.60

28.16

Harvard Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															38.37	35.26	33.05	28.16	29.34

Harvard Bioscience (FRA:HBI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Harvard Bioscience Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (FRA:HBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (FRA:HBI) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

HBIO:USA HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.